Epidemiology and prognosis of breast cancer in young women von Assi, Hussein A, Khoury, Katia E, Dbouk, Haifa, Khalil, Lana E, Mouhieddine, Tarek H, El Saghir, Nagi S

Volltext

Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide von El Saghir, Nagi S, Keating, Nancy L, Carlson, Robert W, Khoury, Katia E, Fallowfield, Lesley

Volltext

Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart... von Khoury, Katia, Lynce, Filipa, Barac, Ana, Geng, Xue, Dang, Chau, Yu, Anthony F., Smith, Karen L., Gallagher, Christopher, Pohlmann, Paula R., Nunes, Raquel, Herbolsheimer, Pia, Warren, Robert, Srichai, Monvadi B., Hofmeyer, Mark, Asch, Federico, Tan, Ming, Isaacs, Claudine, Swain, Sandra M.

Volltext

Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study von Lynce, Filipa, Mainor, Candace, Donahue, Renee N., Geng, Xue, Jones, Greg, Schlam, Ilana, Wang, Hongkun, Toney, Nicole J., Jochems, Caroline, Schlom, Jeffrey, Zeck, Jay, Gallagher, Christopher, Nanda, Rita, Graham, Deena, Stringer-Reasor, Erica M., Denduluri, Neelima, Collins, Julie, Chitalia, Ami, Tiwari, Shruti, Nunes, Raquel, Kaltman, Rebecca, Khoury, Katia, Gatti-Mays, Margaret, Tarantino, Paolo, Tolaney, Sara M., Swain, Sandra M., Pohlmann, Paula, Parsons, Heather A., Isaacs, Claudine

Volltext

Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study von Lynce, Filipa, Mainor, Candace, Donahue, Renee N., Geng, Xue, Jones, Greg, Schlam, Ilana, Wang, Hongkun, Toney, Nicole J., Jochems, Caroline, Schlom, Jeffrey, Zeck, Jay, Gallagher, Christopher, Nanda, Rita, Graham, Deena, Stringer-Reasor, Erica M., Denduluri, Neelima, Collins, Julie, Chitalia, Ami, Tiwari, Shruti, Nunes, Raquel, Kaltman, Rebecca, Khoury, Katia, Gatti-Mays, Margaret, Tarantino, Paolo, Tolaney, Sara M., Swain, Sandra M., Pohlmann, Paula, Parsons, Heather A., Isaacs, Claudine

Volltext

BRCA1 and BRCA2 Mutations in Ethnic Lebanese Arab Women With High Hereditary Risk Breast Cancer von El Saghir, Nagi S., Zgheib, Nathalie K., Assi, Hussein A., Khoury, Katia E., Bidet, Yannick, Jaber, Sara M., Charara, Raghid N., Farhat, Rania A., Kreidieh, Firas Y., Decousus, Stephanie, Romero, Pierre, Nemer, Georges M., Salem, Ziad, Shamseddine, Ali, Tfayli, Arafat, Abbas, Jaber, Jamali, Faek, Seoud, Muhieddine, Armstrong, Deborah K., Bignon, Yves‐Jean, Uhrhammer, Nancy

Volltext

Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer von Khoury, Katia, Tan, Antoinette R, Elliott, Andrew, Xiu, Joanne, Gatalica, Zoran, Heeke, Arielle L, Isaacs, Claudine, Pohlmann, Paula R, Schwartzberg, Lee S, Simon, Michael, Korn, W Michael, Swain, Sandra M, Lynce, Filipa

Volltext

472 Utility of [89Zr]Trastuzumab-PET/MRI Imaging for Quantitative Assessment of Tumor Heterogeneity In HER2+ Breast Cancer von Mansur, Ameer, Nikpanah, Moozhan, McConathy, Johnathan, Stringer-Reasor, Erica, Rocque, Gabrielle, Elkhanany, Ahmed, Khoury, Katia, Jahan, Nusrat, Lapi, Suzanne E., Sorace, Anna G.

Volltext

Re: Tumor boards and the quality of cancer care von El Saghir, Nagi S, Assi, Hussein A, Khoury, Katia E, El Zawawy, Ahmad M, Abbas, Jaber A, Eid, Toufic A

Volltext

Outcome of Breast Cancer Patients Treated outside of Clinical Trials von El Saghir, Nagi S, Assi, Hussein A, Jaber, Sara M, Khoury, Katia E, Nachef, Zahi, Mikdashi, Hana F, El-Asmar, Nadine S, Eid, Toufic A

Volltext

Therapeutic Clinical Trial Eligibility and Enrollment among Women with Breast Cancer: Implications for Understanding Trial Disparities von Reh, Nicole, Caston, Nicole E., Williams, Courtney P., Dwarampudi, Sindhu R., Elkhanany, Ahmed, Khoury, Katia, Stringer-Reasor, Erica, Jahan, Nusrat, Rocque, Gabrielle B., Gutnik, Lily A.

Volltext

A phase 2 study of HER3-DXd in patients (pts) with metastatic breast cancer (MBC) von Hamilton, Erika P., Dosunmu, Ololade, Shastry, Mythili, Finney, Lindsey, Sellami, Dalila B., Sternberg, David W., Wright-Browne, Vance, Toppmeyer, Deborah, Gwin, William R, Thaddeus, J. Thaddeus, Cultrera, Jennifer L., Bagegni, Nusayba Ali, Khoury, Katia, Heeke, Arielle Lutterman, Yuan, Yuan

Volltext

Cardiac dysfunction (CD) among breast cancer survivors (BCS): Role of cardiotoxic therapy and cardiovascular risk factors von Bostany, Geoffrey S., Chen, Yanjun, Francisco, Liton, Dai, Chen, Meng, Qingrui, Sparks, Jessica R, Sessions, Min, Nabell, Lisle, Stringer-Reasor, Erica Michelle, Khoury, Katia, Lenneman, Carrie, Keene, Kimberly Sue, Landier, Wendy, Bhatia, Smita

Volltext

Practice and Impact of Multidisciplinary Tumor Boards on Patient Management: A Prospective Study von Charara, Raghid N, Kreidieh, Firas Y, Farhat, Rania A, Al-Feghali, Karine A, Khoury, Katia E, Haydar, Ali, Nassar, Lara, Berjawi, Ghina, Shamseddine, Ali, El Saghir, Nagi S

Volltext

Risk and Prevention for Highly Penetrant Genes von Chitalia, Ami, Khoury, Katia, Isaacs, Claudine

Volltext

Abstract PD9-02: Peripheral immune subsets and circulating tumor DNA (ctDNA) in patients (pts) with residual triple negative breast cancer (TNBC) treated with adjuvant immunotherap... von Lynce, Filipa, Mainor, Candace, Geng, Xue, Jones, Greg, Schlam, Ilana, Wang, Hongkun, Feger, Ute, Donahue, Renee, Toney, Nicole, Jochems, Caroline, Schlom, Jeffrey, Gallagher, Christopher, Nanda, Rita, Graham, Deena, Stringer-Reasor, Erica M, Denduluri, Neelima, Collins, Julie, Dilawari, Asma A, Chitalia, Ami, Tiwari, Shruti, Nunes, Raquel, Kaltman, Rebecca, Khoury, Katia, Gatti-Mays, Margaret, Swain, Sandra M, Parsons, Heather A., Pohlmann, Paula, Isaacs, Claudine

Volltext

Molecular characterization of trophoblast cell surface antigen 2 (Trop-2) positive triple negative breast cancer (TNBC) von Khoury, Katia, Feldman, Rebecca, Pohlmann, Paula Raffin, Heeke, Arielle Lutterman, Gatalica, Zoran, Veloso, Yvonne, Vidal, Gregory A., Schwartzberg, Lee S., Swain, Sandra M., Isaacs, Claudine, Lynce, Filipa

Volltext

Abstract B088: The Alabama Hereditary Cancer Cohort – New strategies for African American recruitment von Merner, Nancy, Stallworth, Elizabeth, Reasor, Erica, Khoury, Katia, Gutnik, Lily, Farmer, Meagan, Johnson, Brandon

Volltext

Datopotamab–deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial von Khoury, Katia, Meisel, Jane L., Yau, Christina, Rugo, Hope S., Nanda, Rita, Davidian, Marie, Tsiatis, Butch, Chien, A. Jo, Wallace, Anne M., Arora, Mili, Rozenblit, Mariya, Hershman, Dawn L., Zimmer, Alexandra, Clark, Amy S., Beckwith, Heather, Elias, Anthony D., Stringer-Reasor, Erica, Boughey, Judy C., Nangia, Chaitali, Vaklavas, Christos, Omene, Coral, Albain, Kathy S., Kalinsky, Kevin M., Isaacs, Claudine, Tseng, Jennifer, Roussos Torres, Evanthia T., Thomas, Brittani, Thomas, Alexandra, Sanford, Amy, Balassanian, Ronald, Ewing, Cheryl, Yeung, Kay, Sauder, Candice, Sanft, Tara, Pusztai, Lajos, Trivedi, Meghna S., Outhaythip, Ashton, Li, Wen, Onishi, Natsuko, Asare, Adam L., Beineke, Philip, Norwood, Peter, Brown-Swigart, Lamorna, Hirst, Gillian L., Matthews, Jeffrey B., Moore, Brian, Fraser Symmans, W., Price, Elissa, Beedle, Carolyn, Perlmutter, Jane, Pohlmann, Paula, Shatsky, Rebecca A., DeMichele, Angela, Yee, Douglas, van ‘t Veer, Laura J., Hylton, Nola M., Esserman, Laura J.

Volltext

Abstract P4-09-04: Prevalence of phosphatidylinositol-3-kinase (PI3K) pathway alterations and co-alteration of other markers in breast cancer von Khoury, Katia, Tan, Antoinette, Elliott, Andrew, Xiu, Joanne, Gatalica, Zoran, Heeke, Arielle L, Isaacs, Claudine, Pohlmann, Paula R, Schwartzberg, Lee S, Simon, Michael, Korn, Michael W, Swain, Sandra M, Lynce, Filipa

Volltext